Asure Q3 revenue up 10%, recurring revenue up 16%, net loss narrows to $0.6M

What happened

Asure Software reported Q3 2026 revenue of $40.0 million, up 10% year over year, with recurring revenue of $36.9 million rising 16% to 92% of total revenue. The company narrowed its net loss to $0.6 million from $5.4 million a year ago, while EBITDA doubled to $7.9 million and adjusted EBITDA climbed to $10.5 million, a 26% margin. For the first nine months, revenue reached $119.9 million (up 18%) and adjusted EBITDA hit $30.6 million (25.5% margin), versus $20.7 million in the prior-year period. Despite the improvement, Asure remains unprofitable on a GAAP basis and carries interest expense of roughly 4% of revenue, with no commentary yet on AsureCentral migration or customer attach metrics. The results land within the range implied by FY2026 guidance of $159-163 million revenue and 23-25% adjusted EBITDA margin, but the third quarter's 10% growth represents a deceleration from the 18% nine-month pace, likely reflecting tougher comparisons and acquisition lapping.

Implication

Investors should view Q3 as confirming the base-case operating trajectory but not yet resolving the thesis's key risks: GAAP profitability, interest coverage, and cash conversion. Adjusted EBITDA margin of 26% in Q3 exceeds the 23-25% guidance range, suggesting operating leverage is emerging even as revenue growth moderates. However, the persistent net loss and high interest expense mean equity value remains sensitive to any stumble in Q4 or covenant concerns, with the MidCap loan's liquidity floor at $10 million. The absence of AsureCentral adoption metrics in this release is a gap; the market still needs hard evidence that migration is driving attach and retention gains, not just cost savings. A reasonable stance is to hold positions with a trailing stop, expecting the stock to trade between $8 and $10 until Q4 shows either a GAAP profit or a further margin expansion beyond 25%.

Thesis delta

The Q3 print marginally strengthens the base case that Asure can sustain ~24% adjusted EBITDA margins on $160 million revenue, but it does not alter the conviction level because GAAP profitability remains absent. The thesis still hinges on AsureCentral delivering observable attach and retention improvements by Q4 2026, and this release provides no such evidence. Accordingly, the rating remains Potential Buy with the same entry and trim levels, though the probability of the bull case ($10.80) ticks up slightly if Q4 follows a similar margin pattern.